We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PSIL Advisorshares Psychedelics ETF

0.00 (0.00%)
Pre Market
Last Updated: 03:09:37
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Etf Name Etf Symbol Market Stock Type
Advisorshares Psychedelics ETF PSIL AMEX Exchange Traded Fund
  Price Change Price Change % Etf Price Last Trade
0.00 0.00% 1.195 03:09:37
Open Price Low Price High Price Close Price Previous Close
Trades Etfs Traded Average Volume 52 Week Range
0 0 - 1.17 - 2.249
Last Trade Type Quantity Price Currency
- 0  1.195 USD

Advisorshares Psychedelics ETF Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 6.72M - - - 50.62
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Advisorshares Psychedeli...

Real-Time news about Advisorshares Psychedelics ETF (American Stock Exchange): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PSIL Message Board. Create One! See More Posts on PSIL Message Board See More Message Board Posts

PSIL Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,942-0.045-3.63%
1 Month1.281.321.171.2647,150-0.085-6.64%
3 Months1.531.701.171.4272,503-0.335-21.90%
6 Months1.371.701.171.4363,115-0.175-12.77%
1 Year1.712.2491.171.5348,314-0.515-30.12%
3 Years10.1010.701.172.8034,519-8.91-88.17%
5 Years10.1010.701.172.8034,519-8.91-88.17%

The AdvisorShares Psychedelics ETF (the Fund) seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and (ii) derivatives that have economic characteristics similar to such securities. The Fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The Fund invests in exchange-listed equity securities, including common and preferred stock of U.S. and foreign mid, small and micro-capitalization companies, and in total return swaps intended to provide exposure to such companies.

Your Recent History

Delayed Upgrade Clock